$3.61
0.061.69%
At Close: -
$3.64
0.030.83%
After Hours: 7:30 PM EDT
15 minutes delayed
want to know what
the Bulls & Bears Say?
Accolade (NASDAQ:ACCD) 주식, 분석가 평가, 목표 가격, 예측
Accolade Inc의 합의된 목표 주가는 96개의 최신 애널리스트 평가를 살펴보고 설정되었습니다. 마지막 3개의 애널리스트 평가는 6월 28, 2024에 Guggenheim, Stifel 및 Truist Securities에서 발표되었습니다. Guggenheim, Stifel 및 Truist Securities 사이의 평균 목표 주가는 $7.67로, 이러한 3개의 애널리스트 평가에서 Accolade Inc에 대한 암시된 110.62% upside가 있습니다.
추천을 하는 애널리스트 회사들1
Guggenheim
Stifel
Truist Securities
Morgan Stanley
Barclays
1애널리스트 평가로부터 계산됨
Accolade에 대한 애널리스트 평점
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/28/2024 | Buy Now | 64.84% | Guggenheim | Sandy Draper | $13 → $6 | Maintains | Buy | Get Alert |
| 06/28/2024 | Buy Now | 119.78% | Stifel | David Grossman | $13 → $8 | Maintains | Buy | Get Alert |
| 06/28/2024 | Buy Now | 147.25% | Truist Securities | Jailendra Singh | $14 → $9 | Maintains | Buy | Get Alert |
| 06/28/2024 | Buy Now | 64.84% | Morgan Stanley | Ricky Goldwasser | $12 → $6 | Maintains | Equal-Weight | Get Alert |
| 06/28/2024 | Buy Now | 51.1% | Barclays | Stephanie Davis | $11 → $5.5 | Maintains | Equal-Weight | Get Alert |
| 06/28/2024 | Buy Now | 257.14% | Canaccord Genuity | Richard Close | $16 → $13 | Maintains | Buy | Get Alert |
| 06/28/2024 | Buy Now | 119.78% | Needham | Ryan MacDonald | $13 → $8 | Maintains | Buy | Get Alert |
| 06/24/2024 | Buy Now | 257.14% | Needham | Ryan MacDonald | $13 → $13 | Reiterates | Buy → Buy | Get Alert |
| 05/08/2024 | Buy Now | 257.14% | Guggenheim | Sandy Draper | $17 → $13 | Maintains | Buy | Get Alert |
| 04/30/2024 | Buy Now | 174.73% | Wells Fargo | Stan Berenshteyn | $12 → $10 | Maintains | Equal-Weight | Get Alert |
| 04/26/2024 | Buy Now | 229.67% | Morgan Stanley | Ricky Goldwasser | $13 → $12 | Maintains | Equal-Weight | Get Alert |
| 04/26/2024 | Buy Now | 284.62% | Truist Securities | Jailendra Singh | $16 → $14 | Maintains | Buy | Get Alert |
| 04/26/2024 | Buy Now | 339.56% | Canaccord Genuity | Richard Close | $18 → $16 | Maintains | Buy | Get Alert |
| 04/26/2024 | Buy Now | 202.2% | Barclays | — | $13 → $11 | Maintains | Equal-Weight | Get Alert |
| 04/26/2024 | Buy Now | 257.14% | Needham | Ryan MacDonald | $12 → $13 | Maintains | Buy | Get Alert |
| 04/22/2024 | Buy Now | 257.14% | Stifel | David Grossman | $15 → $13 | Maintains | Buy | Get Alert |
| 02/26/2024 | Buy Now | 339.56% | Leerink Partners | Michael Cherny | → $16 | Initiates | → Outperform | Get Alert |
| 01/19/2024 | Buy Now | 367.03% | Needham | Ryan MacDonald | → $17 | Reiterates | Buy → Buy | Get Alert |
| 01/09/2024 | Buy Now | 339.56% | Raymond James | John Ransom | $12 → $16 | Maintains | Outperform | Get Alert |
| 01/09/2024 | Buy Now | 312.09% | Piper Sandler | Jessica Tassan | $12 → $15 | Maintains | Overweight | Get Alert |
| 01/09/2024 | Buy Now | 339.56% | Truist Securities | Jailendra Singh | $15 → $16 | Maintains | Buy | Get Alert |
| 01/09/2024 | Buy Now | 229.67% | Wells Fargo | Stan Berenshteyn | $10 → $12 | Maintains | Equal-Weight | Get Alert |
| 01/04/2024 | Buy Now | 312.09% | Stifel | David Grossman | $17 → $15 | Maintains | Buy | Get Alert |
| 11/22/2023 | Buy Now | 229.67% | Piper Sandler | Jessica Tassan | $15 → $12 | Maintains | Overweight | Get Alert |
| 10/11/2023 | Buy Now | 174.73% | Wells Fargo | Stan Berenshteyn | $14 → $10 | Maintains | Equal-Weight | Get Alert |
| 10/05/2023 | Buy Now | 367.03% | Canaccord Genuity | Richard Close | $18 → $17 | Maintains | Buy | Get Alert |
| 10/05/2023 | Buy Now | 312.09% | Truist Securities | Jailendra Singh | $17 → $15 | Maintains | Buy | Get Alert |
| 10/05/2023 | Buy Now | 394.51% | Stephens & Co. | Jeff Garro | → $18 | Reiterates | Overweight → Overweight | Get Alert |
| 10/05/2023 | Buy Now | 229.67% | Raymond James | John Ransom | $15 → $12 | Maintains | Outperform | Get Alert |
| 10/02/2023 | Buy Now | 367.03% | Truist Securities | Jailendra Singh | → $17 | Reiterates | Buy → Buy | Get Alert |
| 10/02/2023 | Buy Now | 367.03% | Needham | Ryan MacDonald | → $17 | Reiterates | Buy → Buy | Get Alert |
| 08/14/2023 | Buy Now | 394.51% | Stephens & Co. | Jeff Garro | → $18 | Reiterates | Overweight → Overweight | Get Alert |
| 07/03/2023 | Buy Now | 284.62% | Morgan Stanley | Ricky Goldwasser | $14 → $14 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/30/2023 | Buy Now | 367.03% | Stifel | David Grossman | $15 → $17 | Maintains | Buy | Get Alert |
| 06/30/2023 | Buy Now | 284.62% | Morgan Stanley | Ricky Goldwasser | $14 → $14 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/30/2023 | Buy Now | 284.62% | Wells Fargo | Stan Berenshteyn | $13 → $14 | Maintains | Equal-Weight | Get Alert |
| 06/30/2023 | Buy Now | 312.09% | Credit Suisse | Jonathan Yong | $13 → $15 | Maintains | Neutral | Get Alert |
| 06/30/2023 | Buy Now | 367.03% | Needham | Ryan MacDonald | $15 → $17 | Maintains | Buy | Get Alert |
| 06/26/2023 | Buy Now | 312.09% | Needham | Ryan MacDonald | → $15 | Reiterates | Buy → Buy | Get Alert |
| 06/22/2023 | Buy Now | 284.62% | Morgan Stanley | Ricky Goldwasser | → $14 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 05/24/2023 | Buy Now | 353.3% | B of A Securities | Michael Cherny | → $16.5 | Upgrade | Neutral → Buy | Get Alert |
| 05/01/2023 | Buy Now | 339.56% | DA Davidson | Robert Simmons | $14 → $16 | Maintains | Buy | Get Alert |
| 04/28/2023 | Buy Now | 394.51% | Guggenheim | Sandy Draper | $16 → $18 | Maintains | Buy | Get Alert |
| 04/28/2023 | Buy Now | 284.62% | Morgan Stanley | Ricky Goldwasser | $11 → $14 | Maintains | Equal-Weight | Get Alert |
| 04/28/2023 | Buy Now | 257.14% | Credit Suisse | Jonathan Yong | → $13 | Reiterates | → Neutral | Get Alert |
| 04/28/2023 | Buy Now | 394.51% | Canaccord Genuity | Richard Close | $14 → $18 | Maintains | Buy | Get Alert |
| 04/28/2023 | Buy Now | 312.09% | Needham | Ryan MacDonald | → $15 | Reiterates | → Buy | Get Alert |
| 04/25/2023 | Buy Now | 257.14% | Credit Suisse | Jonathan Yong | $11 → $13 | Maintains | Neutral | Get Alert |
| 04/21/2023 | Buy Now | 257.14% | Wells Fargo | Stan Berenshteyn | $10 → $13 | Maintains | Equal-Weight | Get Alert |
| 04/12/2023 | Buy Now | 394.51% | Stephens & Co. | Jeff Garro | → $18 | Initiates | → Overweight | Get Alert |
| 03/28/2023 | Buy Now | 298.35% | B of A Securities | Michael Cherny | $12.5 → $14.5 | Maintains | Neutral | Get Alert |
| 03/23/2023 | Buy Now | 339.56% | Guggenheim | Sandy Draper | → $16 | Upgrade | Neutral → Buy | Get Alert |
| 02/09/2023 | Buy Now | 284.62% | Jefferies | Glen Santangelo | → $14 | Downgrade | Buy → Hold | Get Alert |
| 02/02/2023 | Buy Now | 312.09% | Raymond James | John Ransom | → $15 | Initiates | → Outperform | Get Alert |
| 01/30/2023 | Buy Now | 284.62% | Truist Securities | Jailendra Singh | $12 → $14 | Maintains | Buy | Get Alert |
| 01/06/2023 | Buy Now | 202.2% | Morgan Stanley | Ricky Goldwasser | $12 → $11 | Maintains | Equal-Weight | Get Alert |
| 10/12/2022 | Buy Now | 174.73% | Wells Fargo | Stan Berenshteyn | $8 → $10 | Maintains | Equal-Weight | Get Alert |
| 10/07/2022 | Buy Now | 339.56% | Goldman Sachs | Cindy Motz | $14.5 → $16 | Maintains | Buy | Get Alert |
| 10/07/2022 | Buy Now | 202.2% | Credit Suisse | Jonathan Yong | $9 → $11 | Maintains | Neutral | Get Alert |
| 10/07/2022 | Buy Now | 257.14% | SVB Leerink | Stephanie Davis | $8 → $13 | Maintains | Market Perform | Get Alert |
| 10/04/2022 | Buy Now | 257.14% | Piper Sandler | Jessica Tassan | $12 → $13 | Maintains | Overweight | Get Alert |
| 10/04/2022 | Buy Now | 312.09% | Needham | Ryan MacDonald | $12 → $15 | Maintains | Buy | Get Alert |
| 10/03/2022 | Buy Now | 312.09% | Canaccord Genuity | Richard Close | $12 → $15 | Maintains | Buy | Get Alert |
| 09/21/2022 | Buy Now | 298.35% | Goldman Sachs | Cindy Motz | $13 → $14.5 | Maintains | Buy | Get Alert |
| 09/14/2022 | Buy Now | 229.67% | Morgan Stanley | Ricky Goldwasser | $9 → $12 | Maintains | Equal-Weight | Get Alert |
| 09/08/2022 | Buy Now | 229.67% | Piper Sandler | Jessica Tassan | → $12 | Assumes | → Overweight | Get Alert |
| 09/07/2022 | Buy Now | 312.09% | Truist Securities | Jailendra Singh | → $15 | Initiates | → Buy | Get Alert |
| 08/12/2022 | Buy Now | 339.56% | DA Davidson | Robert Simmons | → $16 | Initiates | → Buy | Get Alert |
| 07/05/2022 | Buy Now | 119.78% | Wells Fargo | Stan Berenshteyn | $6 → $8 | Maintains | Equal-Weight | Get Alert |
| 07/01/2022 | Buy Now | 229.67% | Canaccord Genuity | Richard Close | $17 → $12 | Maintains | Buy | Get Alert |
| 07/01/2022 | Buy Now | 257.14% | Goldman Sachs | Cindy Motz | $15 → $13 | Maintains | Buy | Get Alert |
| 05/26/2022 | Buy Now | 312.09% | Goldman Sachs | Cindy Motz | $26 → $15 | Maintains | Buy | Get Alert |
| 05/02/2022 | Buy Now | 64.84% | Wells Fargo | Stan Berenshteyn | → $6 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 04/29/2022 | Buy Now | — | BTIG | David Larsen | — | Downgrade | Buy → Neutral | Get Alert |
| 04/29/2022 | Buy Now | 147.25% | B of A Securities | Michael Cherny | $45 → $9 | Downgrade | Buy → Neutral | Get Alert |
| 04/29/2022 | Buy Now | 202.2% | Piper Sandler | Jeff Garro | $22 → $11 | Maintains | Overweight | Get Alert |
| 04/29/2022 | Buy Now | 229.67% | Needham | Ryan MacDonald | $33 → $12 | Maintains | Buy | Get Alert |
| 04/29/2022 | Buy Now | 119.78% | SVB Leerink | Stephanie Davis Demko | $52 → $8 | Downgrade | Outperform → Market Perform | Get Alert |
| 04/29/2022 | Buy Now | 147.25% | Morgan Stanley | Ricky Goldwasser | $30 → $9 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/29/2022 | Buy Now | 147.25% | Credit Suisse | Jonathan Yong | $33 → $9 | Downgrade | Outperform → Neutral | Get Alert |
| 04/11/2022 | Buy Now | 147.25% | Wells Fargo | Stan Berenshteyn | → $9 | Initiates | → Underweight | Get Alert |
| 04/07/2022 | Buy Now | — | Guggenheim | Sandy Draper | — | Initiates | → Neutral | Get Alert |
| 03/03/2022 | Buy Now | 806.59% | Credit Suisse | Jailendra Singh | $43 → $33 | Maintains | Outperform | Get Alert |
| 02/11/2022 | Buy Now | 779.12% | Goldman Sachs | Cindy Motz | → $32 | Initiates | → Buy | Get Alert |
| 01/11/2022 | Buy Now | 724.18% | Morgan Stanley | Ricky Goldwasser | $31 → $30 | Maintains | Overweight | Get Alert |
| 01/11/2022 | Buy Now | 806.59% | Needham | Ryan MacDonald | $56 → $33 | Maintains | Buy | Get Alert |
| 12/17/2021 | Buy Now | 751.65% | Morgan Stanley | — | — | Maintains | Overweight | Get Alert |
| 12/02/2021 | Buy Now | 806.59% | Jefferies | Glen Santangelo | — | Initiates | → Buy | Get Alert |
| 10/11/2021 | Buy Now | 1438.46% | Morgan Stanley | — | — | Maintains | Overweight | Get Alert |
| 10/08/2021 | Buy Now | 1603.3% | Credit Suisse | Jailendra Singh | — | Maintains | Outperform | Get Alert |
| 10/08/2021 | Buy Now | 1438.46% | Needham | Ryan MacDonald | — | Maintains | Buy | Get Alert |
| 10/08/2021 | Buy Now | 1328.57% | SVB Leerink | Stephanie Davis | — | Maintains | Outperform | Get Alert |
| 09/30/2021 | Buy Now | 1575.82% | Berenberg | — | — | Initiates | → Buy | Get Alert |
| 09/17/2021 | Buy Now | 1383.52% | Baird | Vikram Kesavabhotla | — | Upgrade | Neutral → Outperform | Get Alert |
| 07/09/2021 | Buy Now | 1768.13% | Needham | Ryan MacDonald | — | Maintains | Buy | Get Alert |
| 07/07/2021 | Buy Now | 1823.08% | Credit Suisse | Jailendra Singh | — | Maintains | Outperform | Get Alert |
FAQ
Accolade (ACCD) 주식의 목표가는 얼마인가요?
Accolade (NASDAQ:ACCD)의 최신 목표 주가는 6월 28, 2024에 Guggenheim에 의해 보고되었습니다. 이 애널리스트 기관은 $6.00에 대한 가격 목표를 설정했으며, 12개월 이내에 ACCD이(가) rise될 것으로 예상합니다 (가능한 64.84% upside). 지난 1년간 32개의 애널리스트 기관이 평가를 보고했습니다.
Accolade (ACCD)에 대한 가장 최근의 애널리스트 평가는 무엇인가요?
Accolade (NASDAQ:ACCD)에 대한 최신 애널리스트 평가는 Guggenheim에 의해 제공되었으며, Accolade은(는) buy 평가를 유지했다합니다.
Accolade (ACCD)에 대한 마지막 업그레이드는 언제 있었나요?
Accolade Inc에 대한 마지막 업그레이드는 5월 24, 2023에 발생했습니다. 이 때 B of A Securities는 $16.5로 가격 목표를 올렸습니다. B of A Securities는 이전에 Accolade Inc에 대해 a neutral를 가지고 있었습니다.
Accolade (ACCD)에 대한 마지막 다운그레이드는 언제 있었나요?
Accolade Inc에 대한 마지막 다운그레이드는 2월 9, 2023에 발생했습니다. 이 때 Jefferies가 Accolade Inc에 대해 가격 목표를 N/A에서 $14로 변경했습니다.
Accolade (ACCD)에 대한 다음 애널리스트 평가는 언제 게시 또는 업데이트될 예정인가요?
애널리스트들은 주식 평가를 내리기 위해 철저한 연구를 진행합니다. 이 연구에는 공개된 재무 보고서를 검토하고, Accolade의 경영진 및 고객과 대화하며, 실적 회의 통화를 듣는 것이 포함됩니다. 대부분의 애널리스트들은 이를 매 분기마다 수행하므로, 한 해에는 회사당 애널리스트 당 4번의 평가를 받을 수 있습니다. Accolade에 대한 마지막 평가는 6월 28, 2024에 제출되었으므로, 다음 평가가 6월 28, 2025쯤에 제공될 것으로 예상됩니다.
애널리스트 평가 Accolade (ACCD)가 올바른가요?
평가는 주관적이며 변할 수 있지만, 최신 Accolade (ACCD) 평가는 유지했다로, 가격 목표는 $13.00에서 $6.00으로 조정되었습니다. 현재 Accolade (ACCD)의 가격은 $3.64로, 이는 애널리스트의 예측 범위에서 out of입니다.
검색 애널리스트 평가 및 가격 목표 모든 주식에 대한
사람들이 또한 지켜본다
© 2024 Benzinga | All Rights Reserved